| Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” CH Polman, SC Reingold, G Edan, M Filippi, HP Hartung, L Kappos, ... Annals of neurology 58 (6), 840-846, 2005 | 6613 | 2005 |
| A full genome search in multiple sclerosis GC Ebers, K Kukay, DE Bulman, AD Sadovnick, G Rice, C Anderson, ... Nature genetics 13 (4), 472-476, 1996 | 848 | 1996 |
| Major depression in multiple sclerosis A population-based perspective SB Patten, CA Beck, JVA Williams, C Barbui, LM Metz Neurology 61 (11), 1524-1527, 2003 | 718 | 2003 |
| A population‐based study of multiple sclerosis in twins: update AD Sadovnick, H Armstrong, GPA Rice, D Bulman, L Hashimoto, ... Annals of neurology 33 (3), 281-285, 1993 | 663 | 1993 |
| The promise of minocycline in neurology VW Yong, R Zabad, T Todoruk, LM Metz Journal of Neurochemistry 94, 71, 2005 | 623 | 2005 |
| The promise of minocycline in neurology VW Yong, J Wells, F Giuliani, S Casha, C Power, LM Metz The Lancet Neurology 3 (12), 744-751, 2004 | 622 | 2004 |
| Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis V Brundula, NB Rewcastle, LM Metz, CC Bernard, VW Yong Brain 125 (6), 1297-1308, 2002 | 542 | 2002 |
| endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms JA Rogers, L Metz, VW Yong Molecular immunology 53 (4), 421-430, 2013 | 483 | 2013 |
| Long-term medical conditions and major depression: strength of association for specific conditions in the general population SB Patten, CA Beck, A Kassam, JVA Williams, C Barbui, LM Metz The Canadian Journal of Psychiatry 50 (4), 195-202, 2005 | 266 | 2005 |
| Burden of illness of multiple sclerosis: Part I: Cost of illness A Auty, C Belanger, JP Bouchard, DG Brunet, P Duquette, GS Francis, ... Canadian Journal of Neurological Sciences 25 (1), 23-30, 1998 | 242 | 1998 |
| Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population SB Patten, LM Metz, MA Reimer Multiple Sclerosis Journal 6 (2), 115-120, 2000 | 234 | 2000 |
| Regional variation of multiple sclerosis prevalence in Canada CA Beck, LM Metz, LW Svenson, SB Patten Multiple Sclerosis Journal 11 (5), 516-519, 2005 | 233 | 2005 |
| A comparison of health utility measures for the evaluation of multiple sclerosis treatments JD Fisk, MG Brown, IS Sketris, LM Metz, TJ Murray, KJ Stadnyk Journal of Neurology, Neurosurgery & Psychiatry 76 (1), 58-63, 2005 | 232 | 2005 |
| Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis LM Metz, Y Zhang, M Yeung, DG Patry, RB Bell, CA Stoian, VW Yong, ... Annals of neurology 55 (5), 756-756, 2004 | 219 | 2004 |
| Randomized multicenter trial of natalizumab in acute MS relapses Clinical and MRI effects PW O’connor, A Goodman, AJ Willmer-Hulme, MA Libonati, L Metz, ... Neurology 62 (11), 2038-2043, 2004 | 213 | 2004 |
| Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis LM Metz, DKB Li, AL Traboulsee, P Duquette, M Eliasziw, G Cerchiaro, ... New England Journal of Medicine 376 (22), 2122-2133, 2017 | 200 | 2017 |
| Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators VW Yong, RK Zabad, S Agrawal, AG DaSilva, LM Metz Journal of the neurological sciences 259 (1), 79-84, 2007 | 196 | 2007 |
| Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG) J Bakker, L Metz Canadian Journal of Neurological Sciences 31 (2), 265-267, 2004 | 159 | 2004 |
| Major depression and quality of life in individuals with multiple sclerosis J Li Wang, MA Reimer, LM Metz, SB Patten The International Journal of Psychiatry in Medicine 30 (4), 309-317, 2000 | 155 | 2000 |
| The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study RK Zabad, LM Metz, TR Todoruk, Y Zhang, JR Mitchell, M Yeung, ... Multiple Sclerosis Journal 13 (4), 517-526, 2007 | 151 | 2007 |
